These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32234060)

  • 1. Investigation of the immunogenicity of Zika glycan loop.
    Henderson EA; Tam CC; Cheng LW; Ngono AE; Nguyen AV; Shresta S; McGee M; Padgett H; Grill LK; Martchenko Shilman M
    Virol J; 2020 Mar; 17(1):43. PubMed ID: 32234060
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defining the impact of flavivirus envelope protein glycosylation site mutations on sensitivity to broadly neutralizing antibodies.
    Contreras M; Stuart JB; Levoir LM; Belmont L; Goo L
    mBio; 2024 Feb; 15(2):e0304823. PubMed ID: 38193697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Zika virus envelope protein glycan loop regulates virion antigenicity.
    Goo L; DeMaso CR; Pelc RS; Ledgerwood JE; Graham BS; Kuhn RJ; Pierson TC
    Virology; 2018 Feb; 515():191-202. PubMed ID: 29304471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune Reactivity of a 20-mer Peptide Representing the Zika E Glycan Loop Involves the Antigenic Determinants E-152/156/158.
    Frumence E; Haddad JG; Vanwalscappel B; Andries J; Decotter J; Viranaicken W; Gadea G; Desprès P
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33167511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dengue and Zika Virus Domain III-Flagellin Fusion and Glycan-Masking E Antigen for Prime-Boost Immunization.
    Lin HH; Yang SP; Tsai MJ; Lin GC; Wu HC; Wu SC
    Theranostics; 2019; 9(16):4811-4826. PubMed ID: 31367259
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Probing Zika Virus Neutralization Determinants with Glycoprotein Mutants Bearing Linear Epitope Insertions.
    Chambers MT; Schwarz MC; Sourisseau M; Gray ES; Evans MJ
    J Virol; 2018 Sep; 92(18):. PubMed ID: 29976678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of Zika Virus Envelope Protein Domain III as a Target of Human Neutralizing Antibodies.
    Gallichotte EN; Young EF; Baric TJ; Yount BL; Metz SW; Begley MC; de Silva AM; Baric RS
    mBio; 2019 Sep; 10(5):. PubMed ID: 31530669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dengue Virus Envelope Dimer Epitope Monoclonal Antibodies Isolated from Dengue Patients Are Protective against Zika Virus.
    Swanstrom JA; Plante JA; Plante KS; Young EF; McGowan E; Gallichotte EN; Widman DG; Heise MT; de Silva AM; Baric RS
    mBio; 2016 Jul; 7(4):. PubMed ID: 27435464
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational Design of Zika Virus Subunit Vaccine with Enhanced Efficacy.
    Tai W; Chen J; Zhao G; Geng Q; He L; Chen Y; Zhou Y; Li F; Du L
    J Virol; 2019 Sep; 93(17):. PubMed ID: 31189716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structures of the Zika Virus Envelope Protein and Its Complex with a Flavivirus Broadly Protective Antibody.
    Dai L; Song J; Lu X; Deng YQ; Musyoki AM; Cheng H; Zhang Y; Yuan Y; Song H; Haywood J; Xiao H; Yan J; Shi Y; Qin CF; Qi J; Gao GF
    Cell Host Microbe; 2016 May; 19(5):696-704. PubMed ID: 27158114
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ZIKV Envelope Domain-Specific Antibodies: Production, Purification and Characterization.
    Akhras S; Herrlein ML; Elgner F; Holzhauser T; Hildt E
    Viruses; 2019 Aug; 11(8):. PubMed ID: 31412626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human antibodies to the dengue virus E-dimer epitope have therapeutic activity against Zika virus infection.
    Fernandez E; Dejnirattisai W; Cao B; Scheaffer SM; Supasa P; Wongwiwat W; Esakky P; Drury A; Mongkolsapaya J; Moley KH; Mysorekar IU; Screaton GR; Diamond MS
    Nat Immunol; 2017 Nov; 18(11):1261-1269. PubMed ID: 28945244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large-scale analysis of B-cell epitopes of envelope: Implications for Zika vaccine and immunotherapeutic development.
    Almansour I; Alfares R; Aljofi H
    F1000Res; 2018; 7():1624. PubMed ID: 31316749
    [No Abstract]   [Full Text] [Related]  

  • 14. Characterization of two engineered dimeric Zika virus envelope proteins as immunogens for neutralizing antibody selection and vaccine design.
    Yang C; Zeng F; Gao X; Zhao S; Li X; Liu S; Li N; Deng C; Zhang B; Gong R
    J Biol Chem; 2019 Jul; 294(27):10638-10648. PubMed ID: 31138647
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.
    Long F; Doyle M; Fernandez E; Miller AS; Klose T; Sevvana M; Bryan A; Davidson E; Doranz BJ; Kuhn RJ; Diamond MS; Crowe JE; Rossmann MG
    Proc Natl Acad Sci U S A; 2019 Jan; 116(5):1591-1596. PubMed ID: 30642974
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zika Virus-Like Particles Bearing a Covalent Dimer of Envelope Protein Protect Mice from Lethal Challenge.
    De Lorenzo G; Tandavanitj R; Doig J; Setthapramote C; Poggianella M; Sanchez-Velazquez R; Scales HE; Edgar JM; Kohl A; Brewer J; Burrone OR; Patel AH
    J Virol; 2020 Dec; 95(1):. PubMed ID: 33028720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Novel Antigenic Site Spanning Domains I and III of the Zika Virus Envelope Glycoprotein Is the Target of Strongly Neutralizing Human Monoclonal Antibodies.
    Graham SD; Tu HA; McElvany BD; Graham NR; Grinyo A; Davidson E; Doranz BJ; Diehl SA; de Silva AM; Markmann AJ
    J Virol; 2021 Apr; 95(9):. PubMed ID: 33597214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunization with phage virus-like particles displaying Zika virus potential B-cell epitopes neutralizes Zika virus infection of monkey kidney cells.
    Basu R; Zhai L; Contreras A; Tumban E
    Vaccine; 2018 Feb; 36(10):1256-1264. PubMed ID: 29395533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zika Virus Envelope Protein and Antibody Complexes.
    Dai L; Wang Q; Song H; Gao GF
    Subcell Biochem; 2018; 88():147-168. PubMed ID: 29900496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational Engineering and Characterization of an mAb that Neutralizes Zika Virus by Targeting a Mutationally Constrained Quaternary Epitope.
    Tharakaraman K; Watanabe S; Chan KR; Huan J; Subramanian V; Chionh YH; Raguram A; Quinlan D; McBee M; Ong EZ; Gan ES; Tan HC; Tyagi A; Bhushan S; Lescar J; Vasudevan SG; Ooi EE; Sasisekharan R
    Cell Host Microbe; 2018 May; 23(5):618-627.e6. PubMed ID: 29746833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.